Chemotherapy and radiotherapy in advanced local non-small cell lung cancer

Hepatic chemosaturation therapy

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Surgical challenges to retroperitoneal sarcomas

Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype

Clinical trials and drug developments in pancreatic cancer

Putting the theory of personalised medicine into practice

Treatment of ALK+ lung cancer with crizotinib, Profile 1007

The first phase II trial for the management of oesophageal cancer

Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer

Personalised cancer medicine and research: Today’s best practice

Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study